Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
Abhishek Gangrade(University of Alabama at Birmingham), Donald J. Buchsbaum(University of Alabama at Birmingham)
Cited by 46
Related Papers
Treatment of Human Colon Cancer Xenografts with TRA-8 Anti-death Receptor 5 Antibody Alone or in Combination with CPT-11
|Clinical Cancer Research|2008|35